Search Tag: VAP
2025 09 Jul
Ventilator-associated pneumonia (VAP) is the most frequent hospital-acquired infection in patients receiving invasive mechanical ventilation (IMV) globally. It affects up to 40% of ventilated patients, with mortality rates up to 50% for all-cause mortality and 13% for direct VAP-related mortality. VAP significantly increases hospital length of s1Read more
2025 06 May
Ventilator-associated pneumonia (VAP) is a common healthcare-associated infection in ICUs, linked to increased mortality, longer mechanical ventilation, and extended ICU stays. Diagnostic criteria for the first episode of VAP include clinical suspicion, chest x-ray infiltrates, and positive microbiological cultures from lower respiratory tract spe1Read more
2024 26 Nov
Pneumonia is a major global health issue, particularly for critically ill patients in ICUs. It encompasses various types, such as community-acquired pneumonia (CAP), hospital-acquired pneumonia (HAP), and ventilator-associated pneumonia (VAP), each with distinct diagnostic and treatment challenges. Annually, pneumonia contributes to over 2.5 milli1Read more
2023 08 Nov
The use of extracorporeal membrane oxygenation (ECMO) has risen significantly as a rescue therapy for respiratory issues, including those caused by viral infections. Patients on ECMO frequently experience complications like thrombotic events and major bleeding, which are considered ECMO-related issues. However, infections are typically attributed 1Read more
2022 24 May
Ventilator-associated pneumonia (VAP) is a major cause of morbidity and mortality in the ICU. It accounts for nearly 25% of infections in ICU patients. While there are guidelines to treat VAP, uncertainties remain when treating VAP due to Pseudomonas aeruginosa (PA-VAP), and the optimal duration of antibiotic therapy continues to be debated. In 1Read more
2022 19 Apr
The increase of multidrug-resistant (MDR) organisms in ICUs is a well-recognised threat. Due to a lack of development of new pharmaceutical agents, there are now only a few antibiotics that are effective against these organisms. The World Health Organization (WHO) has also highlighted the need to develop a global action plan to address antimicrobia1Read more
2021 20 Jan
The coronavirus has a high incidence of patients with severe acute respiratory syndrome (SARS). Many patients infected with COVID-19 need to be admitted to the ICU for invasive ventilation. They are also at a high risk of developing secondary, ventilator-associated pneumonia (VAP). This is because of breach of natural defences by invasive devices,1Read more
2016 30 May
Case Report Using Nonbronchoscopic BAL Use of the HALYARD* Mini-BAL Sampling Catheter proved invaluable in the case of a patient experiencing complications from abdominal surgery. Dr. Roberto Oggioni has been director of the Department of Anaesthesia and Intensive Care at S. Giovanni di Dio Hospital since 2012, and wrote up the case with col1Read more
2016 17 May
Greater collaboration between ICU nursing and medicine could help to minimise ventilator-associated pneumonia (VAP), according to a study that will be presented at the American Thoracic Society (ATS) 2016 International Conference in San Francisco on 17 May. Previous research has shown that a better nurse work environment and a closed ICU doctor 1Read more
2016 08 Mar
A single centre retrospective study that evaluated the accuracy in high-risk trauma patients of the infection-related ventilator-associated complications (IVAC) algorithm for detecting ventilator-associated pneumonia (VAP) found that it failed to detect nearly three-quarters of patients with VAP. The study is published in Respiratory Care . Foll1Read more
2015 25 May
Ventilator-associated pneumonia (VAP) is the most important nosocomial infection in intensive care units (ICUs). Measures have been taken to prevent morbidity of VAP, such as semi-recumbent body position, hand hygiene, and daily bathing with chlorhexidine gluconate (CHG). However, results of previous studies on the effectiveness of daily chlorhexid1Read more
2014 23 Apr
Kimberly-Clark has launched its new KimVent MICROCUFF Subglottic Suctioning Endotracheal Tube (ETT) specifically designed to prevent microaspiration and provide more effective protection against cross-contamination for both patients and healthcare professionals. The MICROCUFF Subglottic ETT offers more effective subglottic suctioning throu1Read more
2014 24 Feb
Oral hygiene has become a standard procedure in the fight against ventilator associated pneumonia (VAP) in today’s hospitals. Intersurgical is introducing an extended range of oral care products to meet the increasing diversified needs of the practitioners. OroCare Aspire is a new toothbrush with suction-only properties. This brush closes 1Read more
2014 21 Feb
In a recent study published in the March edition of Infection Control and Hospital Epidemiology, a team of researchers share their findings on the diagnosis and treatment of ventilator-associated pneumonia (VAP). With the aims of quantifying and characterising unjustified antimicrobial use for VAP as well as identifying risk factors associa1Read more
2013 11 Oct
Laurent Papazian, M.D., Ph.D., of Hôpital Nord, Marseille, France, and colleagues conducted a study to determine whether statin therapy decreased day-28 mortality among intensive care unit patients with ventilator-associated pneumonia. Observational studies have reported that statins improve outcomes of various infections. Ventilator-assoc1Read more
2013 18 Jun
An initiative that combines a multidisciplinary health care approach with a range of preventive measures could cut the rate of a common airway infection among children in intensive care by more than half, a new study suggests. The research, led by a team at Nationwide Children's Hospital, appears in the June issue of the journal Pediatric Cri1Read more
2013 06 Jun
Implementation of a bundle for prevention of ventilator-associated pneumonia (VAP) in critically ill infants and children may lead to lower rates of VAP in these patients, according to an article in the June issue of Critical Care Nurse (CCN). VAP, the second most common hospital-associated infection in pediatric intensive care units, is linked to1Read more